Cargando…

Randomized Controlled Trial of Exercise in CKD—The RENEXC Study

INTRODUCTION: Home-based, clinically feasible trials in non–dialysis-dependent patients with chronic kidney disease (CKD) are sparse. We compared the effects of 2 different exercise training programs on physical performance, and measured glomerular filtration rate (mGFR) and albuminuria level in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hellberg, Matthias, Höglund, Peter, Svensson, Philippa, Clyne, Naomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609793/ https://www.ncbi.nlm.nih.gov/pubmed/31312771 http://dx.doi.org/10.1016/j.ekir.2019.04.001

Ejemplares similares

Comparing effects of 4 months of two self-administered exercise training programs on physical performance in patients with chronic kidney disease: RENEXC – A randomized controlled trial
por: Hellberg, Matthias, et al.
Publicado: (2018)

Twelve months of exercise training did not halt abdominal aortic calcification in patients with CKD – a sub-study of RENEXC-a randomized controlled trial
por: Zhou, Yunan, et al.
Publicado: (2020)

Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)—a randomized controlled trial
por: Zhou, Yunan, et al.
Publicado: (2019)

A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKD
por: Greenwood, Sharlene A., et al.
Publicado: (2023)

Supervised Exercise Intervention and Overall Activity in CKD
por: Pike, Mindy M., et al.
Publicado: (2020)

An International Delphi Survey on Exercise Priorities in CKD
por: Labib, Mary, et al.
Publicado: (2020)

Changes With Lanthanum Carbonate, Calcium Acetate, and Phosphorus Restriction in CKD: A Randomized Controlled Trial
por: Kovesdy, Csaba P., et al.
Publicado: (2018)

Association of Exercise With Vascular Function in Patients With CKD: A Meta-Analysis of Randomized Controlled Trials
por: Wang, Huan, et al.
Publicado: (2022)

Association Between CKD, Obesity, Cardiometabolic Risk Factors, and Severe COVID-19 Outcomes
por: Sörling, Annika, et al.
Publicado: (2023)

Group-Based Exercise in CKD Stage 3b to 4: A Randomized Clinical Trial
por: Anand, Shuchi, et al.
Publicado: (2021)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

A Pilot Trial on the Effect of Levothyroxine on Proteinuria in Patients With Advanced CKD
por: Blackaller, Guillermo Navarro, et al.
Publicado: (2020)

The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2014)

Impact of CKD on Household Income
por: Morton, Rachael L., et al.
Publicado: (2017)

Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts
por: Canney, Mark, et al.
Publicado: (2023)

Assessment of Plasma Oxalate Concentration in Patients With CKD
por: Pfau, Anja, et al.
Publicado: (2020)

Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)
por: Wang, Ke, et al.
Publicado: (2020)

Prediction of Incident Heart Failure in CKD: The CRIC Study
por: Zelnick, Leila R., et al.
Publicado: (2022)

Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients
por: Wang, Bin, et al.
Publicado: (2020)

To improve the life of patients with kidney disease: the impact of exercise
por: Clyne, Naomi, et al.
Publicado: (2021)

Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD
por: Sommerer, Claudia, et al.
Publicado: (2023)

Soluble ST2 and Galectin-3 and Progression of CKD
por: Alam, Mariam L., et al.
Publicado: (2018)

Progression of Medial Arterial Calcification in CKD
por: Manzoor, Shumila, et al.
Publicado: (2018)

Echocardiography to Screen for Pulmonary Hypertension in CKD
por: Edmonston, Daniel L., et al.
Publicado: (2020)

Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study
por: Bouatou, Yassine, et al.
Publicado: (2018)

Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
por: Schulz, Christina-Alexandra, et al.
Publicado: (2019)

Population Estimates of GFR and Risk Factors for CKD in Guatemala
por: Miller, Ann C., et al.
Publicado: (2021)

Consent for Genetic Biobanking in a Diverse Multisite CKD Cohort
por: Troost, Jonathan P., et al.
Publicado: (2018)

A Qualitative Study of Facilitators and Barriers to Self-Management of CKD
por: Schrauben, Sarah J., et al.
Publicado: (2021)

Exercise training in chronic kidney disease—effects, expectations and adherence
por: Clyne, Naomi, et al.
Publicado: (2021)

APOL1, Acid Load, and CKD Progression
por: Pike, Mindy, et al.
Publicado: (2019)

Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD
por: Wiles, Kate, et al.
Publicado: (2019)

Prevalence of CKD, Diabetes, and Hypertension in Rural Tanzania
por: Ploth, David W., et al.
Publicado: (2018)

Self-reported Medication Adherence and CKD Progression
por: Cedillo-Couvert, Esteban A., et al.
Publicado: (2018)

Diagnosis Patterns of CKD and Anemia in the Japanese Population
por: Kimura, Tomomi, et al.
Publicado: (2020)

Longitudinal Bone Loss Occurs at the Radius in CKD
por: Cailleaux, Pierre-Emmanuel, et al.
Publicado: (2021)

Nephrologists’ Perspectives on Gender Disparities in CKD and Dialysis
por: Tong, Allison, et al.
Publicado: (2021)

Plasma Biomarkers as Risk Factors for Incident CKD
por: Sarnak, Mark J., et al.
Publicado: (2022)

Nonsurgical Periodontal Therapy in CKD: Findings of the Kidney and Periodontal Disease (KAPD) Pilot Randomized Controlled Trial
por: Grubbs, Vanessa, et al.
Publicado: (2019)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qmg00a677t7o4i4d6ij1v6jjr3